Arterial hypertension can cause significant retinal damage, leading to hypertensive retinopathy. Elevated blood pressure alters the structure and function of the retinal microcirculation, resulting in consequences that may compromise vision and reflect systemic vascular injury. As the retina is one of the few structures where blood vessels can be directly observed, fundus examination is a fundamental tool for assessing the extent of vascular compromise in hypertensive patients.
Retinal Vascular Changes
Arterial hypertension leads to progressive remodeling of the retinal microcirculation. Initially, a transient arteriolar vasoconstriction is observed, representing an adaptive mechanism to limit excessive blood flow to retinal capillaries. Over time, however, chronic elevation of blood pressure results in thickening of the arteriolar wall, loss of elasticity, and increased vascular stiffness.
The main retinal changes observable on fundus examination include:
Silver-wiring of arterioles: increased axial reflex due to thickening of the arteriolar wall, characteristic of chronic hypertension.
Pathological arteriovenous crossings: thickened arteries compress adjacent veins, causing deviation of their course and risk of occlusion.
Flame-shaped hemorrhages: small hemorrhages along the retinal nerve fibers, a sign of vascular fragility.
Cotton wool spots: areas of neuronal distress due to microinfarctions of the retina.
Optic disc edema: swelling of the optic disc, a sign of malignant hypertension or hypertensive crisis.
Classification of Hypertensive Retinopathy
The severity of retinal changes is classified according to the Keith, Wagener, and Baker scale, which identifies four progressive stages:
Grade I: mild vascular changes with slight narrowing of the arterioles.
Grade II: more marked changes with silver-wiring of arterioles, tortuosity, and pathological arteriovenous crossings.
Grade III: presence of retinal hemorrhages, cotton wool and hard exudates, indicative of retinal ischemic damage.
Advanced retinal changes usually appear when diastolic blood pressure exceeds 125 mmHg, sustained over time or during rapid pressure increases.
Hypertensive Retinopathy and Cardiovascular Risk
Hypertensive retinopathy is not merely an ocular manifestation of hypertension but also an important prognostic indicator of overall cardiovascular risk. The presence of advanced retinal changes is associated with an increased risk of ischemic stroke, cerebral hemorrhage, and cardiovascular disease, as it reflects widespread microvascular injury. Moreover, progression of retinopathy has been correlated with the progression of chronic kidney disease in hypertensive subjects.
Diagnosis and Monitoring
Fundus examination is the main diagnostic tool for detecting hypertensive retinopathy. In patients with uncontrolled or long-standing hypertension, regular ophthalmological check-ups are recommended.
In addition to direct observation of vascular changes, more advanced tests may be performed, such as retinal fluorescein angiography, useful for assessing retinal perfusion and detecting vascular occlusions, and optical coherence tomography (OCT), used to highlight macular edema and structural retinal damage.
These tests allow monitoring of disease progression and identification of complications that require specific interventions.
Prevention and Treatment
The management of hypertensive retinopathy is primarily based on the strict control of blood pressure. Maintaining optimal blood pressure values is the most effective strategy to prevent the progression of retinal damage and reduce the risk of complications. In patients with early signs of retinopathy, adequate blood pressure control can halt the evolution of the disease and in some cases lead to regression of vascular changes.
In advanced grades of hypertensive retinopathy (Grades III-IV of Keith-Wagener-Baker), in the presence of macular edema, hemorrhages, or retinal ischemia, specific ophthalmologic therapies may be required.
Reserved for cases refractory to anti-VEGF injections.
Anti-inflammatory and anti-edema effect.
Retinal laser therapy (grid or focal laser photocoagulation)
Useful in cases with retinal ischemia or persistent microaneurysms.
Prevents the formation of pathological neovessels.
In the presence of retinal changes, follow-up with ophthalmologic monitoring is necessary.
Regular fundus examination: at least every 6–12 months in hypertensive subjects, with higher frequency in advanced cases.
OCT (Optical Coherence Tomography) → useful for monitoring macular edema.
Retinal fluorescein angiography → assessment of vascular perfusion.
The treatment of hypertensive retinopathy is based on aggressive blood pressure control, which is the most effective intervention to prevent progression of retinal damage.
However, in advanced cases with macular edema, ischemia, or retinal hemorrhages, targeted ophthalmologic therapies such as anti-VEGF injections, corticosteroids, and laser photocoagulation may be necessary.
Regular ophthalmologic follow-up is essential to prevent permanent visual loss.
Conclusion
Hypertensive retinopathy is a clinical manifestation of systemic vascular damage in hypertensive patients and represents a key indicator of the severity of arterial hypertension. Regular ophthalmological monitoring and aggressive control of blood pressure values are essential to prevent retinal and systemic complications. Retinal involvement is not only a sign of organ damage but also a critical warning for the global cardiovascular risk in hypertensive patients and requires continuous follow-up.
References
Wong TY, et al. Hypertensive Retinopathy: Pathophysiology and Clinical Implications. Nat Rev Cardiol. 2014;11(2):82-93.
Keith NM, Wagener HP, Barker NW. Some Different Types of Essential Hypertension: Their Course and Prognosis. Am J Med Sci. 1939;197(3):332-343.
Francois J, De Laey JJ. Vascular Diseases of the Retina. Ophthalmologica. 1982;184(1):1-9.
Caballero B, et al. Retinal Microvascular Abnormalities and Hypertension: Clinical and Prognostic Implications. J Hypertens. 2018;36(7):1391-1399.
Whelton PK, et al. 2017 ACC/AHA Hypertension Guidelines. J Am Coll Cardiol. 2018;71(19):e127-e248.
Williams B, et al. 2018 ESC/ESH Guidelines for the Management of Arterial Hypertension. Eur Heart J. 2018;39(33):3021-3104.
Cheung N, et al. Microvascular disease and retinal vasculature: pathophysiology and clinical implications. Nat Rev Nephrol. 2016;12(12):721-734.
Patton N, et al. Retinal vascular image analysis as a potential screening tool for cerebrovascular disease: a review. J Anat. 2005;206(1):3-10.
Ikram MK, et al. Retinal vascular caliber measurements: clinical significance and research applications. Ophthalmologica. 2013;230(3):124-134.
Cheung CY, et al. Retinal microvascular abnormalities and stroke risk: the Atherosclerosis Risk in Communities Study. Stroke. 2013;44(8):2127-2133.
